Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 2018; 103: 356-87. doi: 10.1016/j.ejca.2018.07.005
Wang F, Shu X, Meszoely I, Pal T, Mayer IA, Yu Z, et al. Overall mortality after diagnosis of breast cancer in men vs women. JAMA Oncol 2019. [Epub ahead of print]. doi: 10.1001/jamaoncol.2019.2803
Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, et al. Breast-cancer screening-viewpoint of the IARC working group. N Engl J Med 2015; 372: 2353-8. doi: 10.1056/NEJMsr1504363
Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, et al. Benefits and harms of breast cancer screening: a systematic review. JAMA - J Am Med Assoc 2015; 314: 1615-34. doi: 10.1001/jama.2015.13183
Biganzoli L, Marotti L, Hart CD, Cataliotti L, Cutuli B, Kühn T, et al. Quality indicators in breast cancer care: an update from the EUSOMA working group. Eur J Cancer 2017; 86: 59-81. doi: 10.1016/j.ejca.2017.08.017
Rosselli Del Turco M, Ponti A, Bick U, Biganzoli L, Cserni G, Cutuli B, et al. Quality indicators in breast cancer care. Eur J Cancer 2010; 46: 2344-56. doi: 10.1016/j.ejca.2010.06.119
Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis [Internet]. Eur Guidel 2006 [cited 2020 Mar 30]. Available from: http://screening.iarc.fr/doc/ND7306954ENC_002.pdf
DORA programme colleagues. [Annual Report on the DORA Breast Cancer National Screening Program 2018]. [Slovenian]. [Internet]. Institute of Oncology Ljubljana - DORA National Breast Cancer Screening Programme 2019 [cited 2020 Mar 30]. Available from: https://dora.onko-i.si/fileadmin/user_upload/Dokumenti/DORA_letno_porocilo_2018_knjiznica.pdf
Rizzo M, Bumpers H, Okoli J, Senior-Crosby D, O’Regan R, Zelnak A, et al. Improving on national quality indicators of breast cancer care in a large public hospital as a means to decrease disparities for african american women. Ann Surg Oncol 2011; 18: 34-9. doi: 10.1245/s10434-010-1204-z
Wilcox N, McNeil JJ. Clinical quality registries have the potential to drive improvements in the appropriateness of care. Med J Aust 2016; 205: S27-9. doi: 10.5694/mja15.00921
Cheng SH, Wang CJ, Lin JL, Horng CF, Lu MC, Asch SM, et al. Adherence to quality indicators and survival in patients with breast cancer. Med Care 2009; 47: 217-25. doi: 10.1097/MLR.0b013e3181893c4a.
Van Dam PA, Verheyden G, Sugihara A, Trinh XB, Van Der Mussele H, Wuyts H, et al. A dynamic clinical pathway for the treatment of patients with early breast cancer is a tool for better cancer care: implementation and prospective analysis between 2002-2010. World J Surg Oncol 2013; 11: 70. doi: 10.1186/1477-7819-11-70
Plavc G, Ratoša I, Žagar T, Zadnik V. Explaining variation in quality of breast cancer care and its impact: a nationwide population-based study from Slovenia. Breast Cancer Res Treat 2019; 175: 585-94. doi: 10.1007/s10549-019-05186-z
Henke G, Knauer M, Ribi K, Hayoz S, Gerard MA. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial. Trials 2018; 19: 667. doi: 10.1186/s13063-018-3021-9
Ojala K, Meretoja TJ, Leidenius MHK. Aesthetic and functional outcome after breast conserving surgery - Comparison between conventional and oncoplastic resection. Eur J Surg Oncol 2017; 43: 658-64. doi:10.1016/j. ejso.2016.11.019
Biganzoli L, Cardoso F, Beishon M, Cameron D, Cataliotti L, Coles CE, et al. The requirements of a specialist breast centre. Breast 2020; 51: 65-84. doi: 10.1016/j.breast.2020.02.003
Van Dam PA, Tomatis M, Marotti L, Heil J, Mansel RE, Rosselli del Turco M, et al. Time trends (2006–2015) of quality indicators in EUSOMA-certified breast centres. Eur J Cancer 2017; 85: 15-22. doi: 10.1016/j. ejca.2017.07.040
Van Dam PA, Tomatis M, Marotti L, Heil J, Wilson R, Rosselli Del Turco M, et al. The effect of EUSOMA certification on quality of breast cancer care. Eur J Surg Oncol 2015; 41: 1423-9. doi: 10.1016/j.ejso.2015.06.006
Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Naume B, Nygård JF. Using clinical cancer registry data for estimation of quality indicators: Results from the Norwegian breast cancer registry. Int J Med Inform 2019; 125: 102-9. doi: 10.1016/j.ijmedinf.2019.03.004